Category Archives: AHPPI News

Cardiac Safety – the industry perspective

Dr Boaz Mendzelevski, BioClinica Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     This year marks the 10th anniversary of the introduction of the ICH E14 guideline which was introduced to provide … Continue reading

Comments Off on Cardiac Safety – the industry perspective

Introduction to EUFEMED & European Training Course in Human Pharmacology

Dr Jörg Täubel, EUFEMED Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     Jörg explained that the AHPPI is a founder member of EUFEMED, which was born after a long gestation on 20 … Continue reading

Comments Off on Introduction to EUFEMED & European Training Course in Human Pharmacology

Use of a Novel Risk Rating System in Early Clinical Trials

Dr Brian Leaker, Respiratory Clinical Trials. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     Brian outlined the structure of his unit and, in particular, the research side of the operation. The … Continue reading

Comments Off on Use of a Novel Risk Rating System in Early Clinical Trials

We’ve setup a company page on Linkedin

To complement the private group that we have had running on Linkedin for some time, we have now opened up a public ‘company page’. You may follow us there!

Comments Off on We’ve setup a company page on Linkedin

Risk Management for Early Trials in Biologicals

Dr Richard FitzGerald, Royal Liverpool University Hospital. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     Starting with TeGenero and referring to subsequent guidelines for Phase I trials from such bodies as … Continue reading

0 Comments

Risk Management in a CRO Phase I Unit

Dr John Lambert, PAREXEL. Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     John introduced his talk by describing the changing face of early phase clinical trials and the potential for ‘risk’ in … Continue reading

0 Comments

AVAILABLE NOW: 2015 AHPPI Conference Presentations

Thursday 29-October-2015 Academy of Medical Sciences, London The presentations from this year’s AHPPI Annual Meeting have been uploaded to the conference page (link).  

Comments Off on AVAILABLE NOW: 2015 AHPPI Conference Presentations

AHPPI Annual Meeting – Programme 29-Oct-2015

Thursday 29th October 2015 Academy of Medical Sciences, London We are pleased to announce the programme for this year’s AHPPI Annual Meeting (link). There will be a range of speakers from commercial and academic backgrounds delivering presentations on a variety … Continue reading

Comments Off on AHPPI Annual Meeting – Programme 29-Oct-2015

Risk Management in Early Phase Clinical Trials

Thursday 29th October 2015 Academy of Medical Sciences, London We are pleased to announce this year’s AHPPI Annual Meeting. There will be a range of speakers from commercial and academic backgrounds delivering presentations on a variety of issues within this … Continue reading

Comments Off on Risk Management in Early Phase Clinical Trials

Faculty conversation: TQT study – this is the end!

Recently, the FDA, other regulatory bodies, and pharmaceutical companies have been exploring options to replace TQTs with preclinical testing or with data collected during standard Phase I trials. Join colleagues from the FPM and also the British Pharmacological Society and … Continue reading

Comments Off on Faculty conversation: TQT study – this is the end!